A Phase IIa Study to Evaluate the Efficacy of OMT-111 in Patients with Metastatic Colorectal Cancer Resistant to Standard Therapies
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2513253
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Drug : 1)Dosage:
OMT-111: 100 mg/day
2)Duration of treatment:
1 cycle consists of 4 weeks (28 days). Each week consists of 5 days of treatment and 2 days of treatment-free interval (20 days of treatment and 8 days of treatment-free interval per cycle in total).
3)Administration:
Subcutaneous injection, once daily, preferably at the same time of the day
Primary outcome(s): Disease control rate, DCR
创建时间：
2020-07-15
